Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Novo Nordisk A/S
Age
18–55
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
FOR TRIAL PART 1, THE FOLLOWING APPLIES:
Gender: male
Age: 18-55 years
BMI (body mass index): 18-28 kg/m2
Study participants considered to be healthy
FOR TRIAL PART 2, THE FOLLOWING APPLIES:
Gender: male or female of no childbearing potential
Age: 18-65 years
Type 1 diabetes: BMI (body mass index): 18-28 kg/m2
Type 2 diabetes: BMI (body mass index): 22-35 kg/m2
Type 1 or type 2 diabetes for at least 12 months
Type 1 diabetes: Treatment with insulin for at least 12 months
Type 2 diabetes: Treatment with insulin for at least 3 months
You may not be if
Known or suspected allergy to the trial product or related products
Presence of illness or infection that may confound the results of the study or pose a risk to the study participant by dosing NN1952, as judged by the Investigator
Presence of acute gastrointestinal symptoms (for example nausea, vomiting, heartburn or diarrhoea)
